Tecovirimat Siga
Tecovirimat (SIGA) Recall Summary The antiviral drug tecovirimat, used to treat poxvirus infections including monkeypox and smallpox, is being restricted in the European Union. The approved uses for this medication are being limited, classified as a Class II recall affecting the EU market.
- Product
- Active substances: tecovirimat monohydrate. Therapeutic area: Poxviridae Infections;Cowpox;Monkeypox;Vaccinia;Smallpox. ATC code: J05AX24
- Reason
- Restriction of indication
- Classification
- Class II
- Category
- drug recall
- Country
- European Union
- Agency
- EMA-DHPC
- Recall date
- 2026-05-11
- Status
- Ongoing
- Distribution
- European Union
Official recall notice from EMA-DHPC
Recall details on Nibble Recalls: https://trynibble.app/recalls/d775fdac-79fb-4df4-8c6c-6f2cd0398a8f